The list of main grants and tasks during last five years.
-
Research project MZ 0002384101
-
IP-REM-AC- clinical study – phase 2/3
-
CECOG/GIST 1.2.001 – phase 3 (Gleevec)
-
20020402- clinical study – phase 3 (Palifermin)
-
Study VIVENTIA VB – 845-01-IIIA (Proxinium)
-
A phase III randomized, stratified, paralel-group, multi-centre, comparative study of ZD 1839 (Iresa) 250 mg and 500 mg versus Methotrexate for reviously treated patients with squamous cell carcinoma of the head and deck
-
ECHOS trial
There are three students on PhD studies.